Hodgkin's Lymphoma: Relapse After Auto SCT, Brentuximab Vedotin, and Checkpoint Inhibitors – The Next Frontier_Anna Sureda, MD, PhD; #IUCLS22
20:00
Lymphoma
Hodgkin's Lymphoma: Relapse After Auto SCT, Brentuximab Vedotin, and Checkpoint Inhibitors – The Next Frontier_Anna Sureda, MD, PhD; #IUCLS22
Lymphoma Similar Videos
Similar Videos
-
Virtual Challenging Case Clinic: B-Cell Lymphomas_Marginal Zone Lymphoma_Peter Martin, MD
51:30
-
Virtual Challenging Case Clinic: B-cell Lymphomas - Chronic Lymphocytic Leukemia_Jennifer Brown, MD, PhD
49:09
-
Virtual Challenging Case Clinic: B-cell Lymphomas_Diffuse Large B-cell Lymphoma_Julie Vose, MD, MBA
47:20
